Testing movement and function in people with hemophilia
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at how well certain tests measure movement and function in people with hemophilia. It may help improve how doctors track your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with hemophilia type A or B.
- You must be at least 18 years old.
- You must be taking treatment for hemophilia, either regularly (prophylaxis) or as needed (on-demand).
- You must be able to walk about 20 meters on your own, even if you use a cane or walker.
- You must not have a serious health condition that affects your heart, lungs, brain, or muscles and bones.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how hemophilia A affects joint health, balance, and quality of life in adults. Researchers will assess your joints and balance to understand the relationship between joint damage and everyday function.
This study compares how two different hemophilia A treatments affect bone strength and health in men over time. Researchers will track bone density and collect blood samples to understand whether one treatment protects bones better than the other.
This study tests if manual therapy can help patients with hemophilia who have arthritis in their ankle. It seeks to improve joint health and reduce pain.
This study checks joint health and bleeding risk in people with severe hemophilia A who are taking newer factor VIII treatments or emicizumab. It uses ultrasound and blood tests to see how well these therapies protect joints.
This study is looking at how well joint health can be tracked in people with severe hemophilia A who are receiving regular factor VIII treatment. It uses special markers in the blood and ultrasound to check for early joint changes.
This study compares how well people with hemophilia (ages 18–35) can do a 30-second sit-to-stand test compared to healthy people of the same age. It helps understand if hemophilia affects leg strength and endurance.
Hear when a new Hemophilia A trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.